The PPAR-Gamma Activator Rosiglitazone Fails to Lower Plasma Growth Hormone and Insulin-Like Growth Factor-1 Levels in Patients with Acromegaly

Publisher： Karger

E-ISSN： 1423-0194|86|2|119-123

ISSN： 0028-3835

Source： Neuroendocrinology, Vol.86, Iss.2, 2007-08, pp. : 119-123

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Acromegaly and Serum Insulin-Like Growth Factor I

By  

Hormone Research in Paediatrics, Vol. 62, Iss. 1, 2005-03 ,pp. : 34-36

Karger

Access to resources Recommend Favorite

Acute Effects of Blood Transfusion on Growth Hormone and Insulin-Like Growth Factor-1 Levels in Children with Thalassemia

By  

Hormone Research in Paediatrics, Vol. 75, Iss. 4, 2010-11 ,pp. : 240-245

Karger

Access to resources Recommend Favorite

Plasma Levels of Insulin-Like Growth Factor (IGF)-I, IGF-II and IGF-Binding Protein-3 in the Evaluation of Childhood Growth Hormone Deficiency

By  

Hormone Research in Paediatrics, Vol. 50, Iss. 3, 1998-10 ,pp. : 166-176

Karger

Access to resources Recommend Favorite

Insulin-Like Growth Factor-Binding Protein-2 Levels in Pediatric Patients with Growth Hormone Deficiency, Eating Disorders and Acute Lymphoblastic Leukemia

By  

Hormone Research in Paediatrics, Vol. 53, Iss. 5, 2000-11 ,pp. : 221-227

Karger

Access to resources Recommend Favorite

The Challenges of Reliance on Insulin-Like Growth Factor I in Monitoring Disease Activity in Patients with Acromegaly

By  

Hormone Research in Paediatrics, Vol. 62, Iss. 1, 2005-03 ,pp. : 83-88

Karger

Access to resources Recommend Favorite